Related Experiment Video
Updated: Nov 10, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Device Therapy of Hypertension.
Felix Mahfoud1,2, Markus P Schlaich3,4,5,6, Melvin D Lobo7,8
1Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany (F.M.).
New interventional therapies target the sympathetic nervous system to control hypertension. Renal denervation is a mature technology, while others require more research for blood pressure management.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
- Neuromodulation
Background:
- Hypertension management traditionally relies on lifestyle changes and medication.
- Emerging interventional therapies focus on the sympathetic nervous system's role in hypertension.
- Peripheral and central nervous system targets are being explored for blood pressure control.
Purpose of the Study:
- To review current and emerging interventional technologies for hypertension management.
- To evaluate the preclinical rationale and human evidence for these novel therapies.
- To highlight areas for future investigation in hypertension treatment.
Main Methods:
- Review of preclinical data and human clinical trials.
- Focus on neuromodulatory techniques targeting the sympathetic nervous system.
- Exploration of both peripheral and central nervous system interventions.
Main Results:
- Renal denervation (using radiofrequency and ultrasound) is the most advanced, showing safety and efficacy.
- Baroreflex activation therapy, endovascular baroreflex amplification, carotid body ablation, and pacemaker-mediated control are developing technologies.
- Central nervous system control and non-sympathetic hemodynamic interventions warrant further investigation.
Conclusions:
- Renal denervation is nearing clinical availability for hypertension treatment.
- Further human data are needed for other neuromodulatory therapies.
- Investigating central nervous system pathways and hemodynamic interventions offers future potential for hypertension control.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of Diuretics
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antihypertensive Drugs: Angiotensin II Receptor Blockers

